783 related articles for article (PubMed ID: 26166767)
1. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of Ly6C
Zhao W; Zhou X; Zhao G; Lin Q; Wang X; Yu X; Wang B
Hum Vaccin Immunother; 2017 Dec; 13(12):2872-2882. PubMed ID: 28699816
[TBL] [Abstract][Full Text] [Related]
3. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
4. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
[TBL] [Abstract][Full Text] [Related]
5. Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice.
Zou Q; Yao X; Feng J; Yin Z; Flavell R; Hu Y; Zheng G; Jin J; Kang Y; Wu B; Liang X; Feng C; Liu H; Li W; Wang X; Wen Y; Wang B
PLoS One; 2011; 6(10):e25525. PubMed ID: 21998665
[TBL] [Abstract][Full Text] [Related]
6. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells.
Roh S; Kim K
Microbiol Immunol; 2003; 47(6):453-60. PubMed ID: 12906106
[TBL] [Abstract][Full Text] [Related]
7. Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice.
Wang Y; Chen K; Wu Z; Liu Y; Liu S; Zou Z; Chen SH; Qu C
Int J Infect Dis; 2014 Dec; 29():31-6. PubMed ID: 25449231
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
12. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
13. Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice.
Qing Y; Chen M; Zhao J; Hu H; Xu H; Ling N; Peng M; Ren H
Vaccine; 2010 Jun; 28(26):4301-7. PubMed ID: 20430121
[TBL] [Abstract][Full Text] [Related]
14. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
[TBL] [Abstract][Full Text] [Related]
15. Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice.
Gao W; Sun Y; Chen S; Zhang J; Kang J; Wang Y; Wang H; Xia G; Liu Q; Kang Y
Vaccine; 2013 Apr; 31(18):2273-80. PubMed ID: 23499522
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
17. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
19. A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X
Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
Sasaki Md; Foccacia R; de Messias-Reason IJ
Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
